Reid Group


Bioanalytical Mass Spectrometry for Proteome and Lipidome Analysis

The focus of the Reid group is on research to develop bioanalytical mass spectrometry and associated chemical and biochemical analysis strategies for proteome and lipidome characterization, and their application toward understanding the role of proteins (particularly those containing post translational modifications) and lipids in disease, including cancer, diabetes and diabetic complications. Visit the Reid Laboratory webpage in the School of Biomedical Sciences, MDHS.

Areas of Interest:

  • Bioanalytical chemistry
  • Lipidomics
  • Proteomics
  • Mass spectrometry
  • Technology Development
  • Colorectal Cancer


  • Mass Spectrometry
  • Chromatography
  • Cell Culture
  • Organic Synthesis
  • Peptide Synthesis


Group Leader

Gavin Reid


Dr Vinzenz Hofferek

PhD Students

Mr Yepy Hardi Rustam

Masters Students

Ms Thy Duong
Ms Haoyun Fang 
Ms Mengxuan Fang
Mr Xinghe Zhang


Ms Huaqi Su



Email: gavin.reid [at]

Tel: (03) 8344 2650

Dr. Gavin E. Reid is the Professor of Bioanalytical Chemistry in the School of Chemistry and the Department of Biochemistry and Molecular Biology at the University of Melbourne. Over the past 30 years, he has held a variety of technical research positions and academic appointments in Australia and the USA, including at the Ludwig Institute for Cancer Research in Melbourne (1987−1997 and 2002− 2004) and at Michigan State University, MI, USA (2004−2014).  Research in the Reid lab is broadly directed toward the development of analytical biochemistry, mass spectrometry, and associated chemical strategies for quantitative lipidome and proteome analysis, and their application toward identifying the functional role of lipids and proteins in the regulation of cellular function, and in the onset and progression of disease, including colorectal cancer. To date, this inter-disciplinary and highly collaborative research has resulted in >150 peer-reviewed publications, >150 conference and invited seminar presentations, and 4 patents, with funding received from the Australian Research Council, the National Health and Medical Research Council, the National Institutes of Health, the National Science Foundation, the Multiple Myeloma Research Foundation, the Juvenile Diabetes Research Foundation, the Centers for Disease Control, and multiple industry, philanthropic and government groups. Gavin served from 2012-2014 on the Board of Directors of the American Society for Mass Spectrometry, and was Treasurer of the Australasian Proteomics Society from 2015-2017. He is currently President of the Australian and New Zealand Society for Mass Spectrometry, an Associate Editor for the Journal of the American Society for Mass Spectrometry, and is on the Editorial Advisory Boards for the Journal of Lipid Research, the Journal of Mass Spectrometry, and the European Journal of Mass Spectrometry.